Schonfeld Strategic Advisors LLC raised its position in DaVita Inc. (NYSE:DVA - Free Report) by 91.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,915 shares of the company's stock after purchasing an additional 9,974 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in DaVita were worth $3,128,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. acquired a new position in DaVita during the 4th quarter worth about $41,000. Coppell Advisory Solutions LLC lifted its position in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Canada Post Corp Registered Pension Plan acquired a new position in shares of DaVita in the fourth quarter valued at approximately $55,000. Venturi Wealth Management LLC increased its stake in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after buying an additional 152 shares during the period. Finally, Versant Capital Management Inc boosted its position in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after buying an additional 169 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently weighed in on DVA shares. Barclays raised their target price on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. StockNews.com upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Cowen restated a "hold" rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $166.33.
Get Our Latest Stock Report on DVA
DaVita Stock Performance
Shares of NYSE:DVA traded up $1.29 during trading on Wednesday, reaching $143.91. The company had a trading volume of 674,067 shares, compared to its average volume of 819,640. DaVita Inc. has a fifty-two week low of $131.44 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock's fifty day moving average price is $145.88 and its 200 day moving average price is $154.27. The firm has a market capitalization of $11.06 billion, a price-to-earnings ratio of 13.40, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14.
DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current year.
DaVita Company Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Stories
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
